Cathepsin D activity protects against development of type AA amyloid fibrils

European Journal of Clinical Investigation

Volumn 39, Issue 5, 2009, Pages 412-416

  Van Der Hilst, J C H ^a   Kluve Beckerman, B ^b   Van Der Meer, J W M ^a   Simon, A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AA amyloidosis; Cathepsin B; Cathepsin D; Cathepsin K

Indexed keywords

AMYLOID A PROTEIN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN K; PEPSTATIN; SERUM AMYLOID A;

AMYLOIDOSIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AMYLOID; CATHEPSIN B; CATHEPSIN D; CATHEPSINS; CELLS, CULTURED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; HYDROGEN-ION CONCENTRATION; LEUKOCYTES, MONONUCLEAR; SERUM AMYLOID A PROTEIN;

EID: 63849239483     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02104.x     Document Type: Article

References (22)

1. Rocken C, Menard R, Buhling F, Vockler S, Raynes J, Stix B et al. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation. Ann Rheum Dis 2005 64 : 808 15.
2. Liepnieks JJ, Kluvebeckerman B, Benson MD. Characterization of amyloid-A protein in human secondary amyloidosis - the predominant deposition of serum amyloid-A1. Biochim Biophys Acta 1995 1270 : 81 6.
3. Kluve-Beckerman B, Manaloor J, Liepnieks JJ. Binding, trafficking and accumulation of serum amyloid A in peritoneal macrophages. Scand J Immunol 2001 53 : 393 400.
4. Chronopoulos S, Laird DW, Ali-Khan Z. Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells: confocal and immunogold electron microscopic studies. J Pathol 1994 173 : 361 9.
5. Chan SL, Chronopoulos S, Murray J, Laird DW, AliKhan Z. Selective localization of murine ApoSAA(1)/SAA(2) in endosomes-lysosomes in activated macrophages and their degradation products. Amyloid 1997 4 : 40 8.
6. Kluve-Beckerman B, Manaloor JJ, Liepnieks JJ. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid. Arthritis Rheum 2002 46 : 1905 13.
7. Takahashi M, Yokota T, Kawano H, Gondo T, Ishihara T, Uchino F. Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophages. Virchows Arch A Pathol Anat Histopathol 1989 415 : 411 9.
8. Shirahama T, Cohen AS. Intralysosomal formation of amyloid fibrils. Am J Pathol 1975 81 : 101 16.
9. Rocken C, Fandrich M, Stix B, Tannert A, Hortschansky P, Reinheckel T et al. Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis. J Pathol 2006 210 : 478 87.
10. Yamada T, Liepnieks JJ, Kluve-Beckerman B, Benson MD. Cathepsin B generates the most common form of amyloid A (76 residues) as a degradation product from serum amyloid A. Scand J Immunol 1995 41 : 94 7.
11. Yamada T, Kluve-Beckerman B, Liepnieks JJ, Benson MD. In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: possible protection against amyloid fibril formation. Scand J Immunol 1995 41 : 570 4.
12. Yamada T, Liepnieks J, Benson MD, Kluve-Beckerman B. Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin. J Immunol 1996 157 : 901 7.
13. Rocken C, Stix B, Bromme D, Ansorge S, Roessner A, Buhling F. A putative role for cathepsin K in degradation of AA and AL amyloidosis. Am J Pathol 2001 158 : 1029 38.
14. Schagger H, Vonjagow G. Tricine sodium dodecyl-sulfate polyacrylamide-Gel Electrophoresis for the separation of proteins in the range from 1-Kda to 100-Kda. Anal Biochem 1987 166 : 368 79.
15. Kluve-Beckerman B, Liepnieks JJ, Wang L, Benson MD. A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am J Pathol 1999 155 : 123 33.
16. van der Hilst JC, Kluve-Beckerman B, Bodar EJ, van der Meer JW, Drenth JP, Simon A. Lovastatin inhibits formation of AA amyloid. J Leukoc Biol 2008 83 : 1295 9.
17. Phipps-Yonas H, Pinard G, Ali-Khan Z. Humoral proinflammatory cytokine and SAA generation profiles and spatio-temporal relationship between SAA and lysosomal cathepsin B and D in murine splenic monocytoid cells during AA amyloidosis. Scand J Immunol 2004 59 : 168 76.
18. Westermark GT, Engstrom U, Westermark P. The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Commun 1992 182 : 27 33.
19. Liu Y, Cui D, Hoshii Y, Kawano H, Une Y, Gondo T et al. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides. Scand J Immunol 2007 66 : 495 500.
20. Kirschner DA, Elliott-Bryant R, Szumowski KE, Gonnerman WA, Kindy MS, Sipe JD et al. In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid-resistant mice. J Struct Biol 1998 124 : 88 98.
21. Elliott-Bryant R, Liang JS, Sipe JD, Cathcart ES. Catabolism of lipid-free recombinant apolipoprotein serum amyloid A by mouse macrophages in vitro results in removal of the amyloid fibril-forming amino terminus. Scand J Immunol 1998 48 : 241 7.
22. Howie AJ, Burnett D, Crocker J. The distribution of cathepsin B in human tissues. J Pathol 1985 145 : 307 14.